Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : The Straight Shooter's Corner -- Ignore unavailable to you. Want to Upgrade?

To: vpelt who wrote (80)	7/30/1999 4:05:00 PM
From: STLMD	Read Replies (1) \| Respond to of 109

vpelt... If Medicare gets into the prescription business watch for some great buying opportunities as you mention. The truth of the matter since government has been involved in healthcare has been that coverage and accessibility has been increased in situations such as these. There may be a retail price lowering, but the demand for drugs now that a govt sponsored program is available will be tremendous. The 15-20% price cut probable under this program will be easily recovered with what I predict to be a 30-40% increase in consumption. This has been the case with Medicaid, all HMO pharmacy prescription plans, the introduction of health insurance since the 1960's and will not change in the foreseeable future. The analysts and pundits just don't study history or... they know history, announce warnings so their companies and clients can buy at distressed prices , and watch prices double or triple once again. Let's hope and pray the Medicare pharmacy benefit gets some life so we can have a great buying opportunity similar to 1990 and 1991. Stephen